Prospective clinical study of moxibustion in the treatment of Parkinson's disease
- Conditions
- Parkinson's disease
- Registration Number
- ITMCTR2000002995
- Lead Sponsor
- Traditional Chinese Medicine Hospital of Bao'an District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) All enrolled patients in accordance with diagnostic criteria.
(2) Patients with Hoehn-yahr (H-Y) grade 1 to 3.
(3) Patientsage under 70 years.
(4) Duration of Parkinson over 6 months.
(5) Patients take pasta hydrazine tablets at least 30 daysand the medication regimen was not adjusted.
(6) Patients sign informed consent.
(1) Various secondary Parkinson's syndrome, Parkinson's syndrome, and Hoehn-yahr (H-Y) > 3.
(2) Patients with dementia and mental disorders and unable to communicate and cooperate.
(3) Patient has a history of severe brain trauma and brain surgery.
(4) Patients have severe systemic organic diseases such as heart, lung, liver, kidney, endocrine diseases and metabolic disorders.
(5) Patients cannot receive moxibustion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MDS-UPDRS scale;SCL-90;BPI;EEG;EMG;PDQ-39;RS-fMRI;FSS;Wexner;PDSS;
- Secondary Outcome Measures
Name Time Method